Helper Virus-Free Herpesvirus Amplicon Particles And Uses Thereof


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

FEDEROFF, HOWARD, J. , BOWERS, WILLIAM, J.

ABSTRACT

The invention features new helper virus-free methods for making herpesvirus amplicon particles that can be used in immunotherapies, including those for treating any number of infectious diseases and cancers (including chronic lymphocytic leukemia, other cancers in which blood cells become malignant, lymphomas (e.g. Hodgkin's lymphoma or non-Hodgkin's type lymphomas). Described herein are methods of making helper virus-free HSV amplicon particles; cells that contain those particles (e.g., packaging cell lines or patients' cells, infected in vivo or ex vivo); particles produced according to those methods; and methods of treating a patient with an hf-HSV particle made according to those methods. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3048", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "FEDEROFF, HOWARD, J.", 
        "type": "Person"
      }, 
      {
        "name": "BOWERS, WILLIAM, J.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ymthe.2005.06.484", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000641515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.24.20.9239-9247.2004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005783741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ymthe.2005.11.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006270516"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-9525(99)01777-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021937163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/75568", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039686973", 
          "https://doi.org/10.1038/75568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ymthe.2003.11.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044603246"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The invention features new helper virus-free methods for making herpesvirus amplicon particles that can be used in immunotherapies, including those for treating any number of infectious diseases and cancers (including chronic lymphocytic leukemia, other cancers in which blood cells become malignant, lymphomas (e.g. Hodgkin's lymphoma or non-Hodgkin's type lymphomas). Described herein are methods of making helper virus-free HSV amplicon particles; cells that contain those particles (e.g., packaging cell lines or patients' cells, infected in vivo or ex vivo); particles produced according to those methods; and methods of treating a patient with an hf-HSV particle made according to those methods.

", "id": "sg:patent.EP-2032173-A2", "keywords": [ "herpesvirus", "invention", "helper", "immunotherapy", "Communicable Disease", "Neoplasm", "B-Cell Chronic Lymphocytic Leukemia", "blood cell", "lymphoma", "Hodgkin's", "method", "amplicons", "cell", "particle", "packaging cell line", "patient cell", "vivo", "ex vivo", "patient" ], "name": "HELPER VIRUS-FREE HERPESVIRUS AMPLICON PARTICLES AND USES THEREOF", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.16416.34", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-2032173-A2" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:31", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_1a463c9e.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-2032173-A2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-2032173-A2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-2032173-A2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-2032173-A2'


 

This table displays all metadata directly associated to this object as RDF triples.

63 TRIPLES      14 PREDICATES      38 URIs      26 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.EP-2032173-A2 schema:about anzsrc-for:3048
2 schema:author Na1451fe897e84309a8d134ec857a99e1
3 schema:citation sg:pub.10.1038/75568
4 https://doi.org/10.1016/j.ymthe.2003.11.024
5 https://doi.org/10.1016/j.ymthe.2005.06.484
6 https://doi.org/10.1016/j.ymthe.2005.11.011
7 https://doi.org/10.1016/s0168-9525(99)01777-1
8 https://doi.org/10.1128/mcb.24.20.9239-9247.2004
9 schema:description <p>The invention features new helper virus-free methods for making herpesvirus amplicon particles that can be used in immunotherapies, including those for treating any number of infectious diseases and cancers (including chronic lymphocytic leukemia, other cancers in which blood cells become malignant, lymphomas (e.g. Hodgkin's lymphoma or non-Hodgkin's type lymphomas). Described herein are methods of making helper virus-free HSV amplicon particles; cells that contain those particles (e.g., packaging cell lines or patients' cells, infected in vivo or ex vivo); particles produced according to those methods; and methods of treating a patient with an hf-HSV particle made according to those methods.</p>
10 schema:keywords B-Cell Chronic Lymphocytic Leukemia
11 Communicable Disease
12 Hodgkin's
13 Neoplasm
14 amplicons
15 blood cell
16 cell
17 ex vivo
18 helper
19 herpesvirus
20 immunotherapy
21 invention
22 lymphoma
23 method
24 packaging cell line
25 particle
26 patient
27 patient cell
28 vivo
29 schema:name HELPER VIRUS-FREE HERPESVIRUS AMPLICON PARTICLES AND USES THEREOF
30 schema:recipient https://www.grid.ac/institutes/grid.16416.34
31 schema:sameAs https://app.dimensions.ai/details/patent/EP-2032173-A2
32 schema:sdDatePublished 2019-03-07T15:31
33 schema:sdLicense https://scigraph.springernature.com/explorer/license/
34 schema:sdPublisher N027b577ca2684dd5a80465d1e5c929c9
35 sgo:license sg:explorer/license/
36 sgo:sdDataset patents
37 rdf:type sgo:Patent
38 N027b577ca2684dd5a80465d1e5c929c9 schema:name Springer Nature - SN SciGraph project
39 rdf:type schema:Organization
40 N03a6ec8023a14a219726a6b653eca1cc rdf:first N44386836fe2e4563b0c512f84046b0cb
41 rdf:rest rdf:nil
42 N44386836fe2e4563b0c512f84046b0cb schema:name BOWERS, WILLIAM, J.
43 rdf:type schema:Person
44 N86693cb898b2450087ff2cc39179b521 schema:name FEDEROFF, HOWARD, J.
45 rdf:type schema:Person
46 Na1451fe897e84309a8d134ec857a99e1 rdf:first N86693cb898b2450087ff2cc39179b521
47 rdf:rest N03a6ec8023a14a219726a6b653eca1cc
48 anzsrc-for:3048 schema:inDefinedTermSet anzsrc-for:
49 rdf:type schema:DefinedTerm
50 sg:pub.10.1038/75568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039686973
51 https://doi.org/10.1038/75568
52 rdf:type schema:CreativeWork
53 https://doi.org/10.1016/j.ymthe.2003.11.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044603246
54 rdf:type schema:CreativeWork
55 https://doi.org/10.1016/j.ymthe.2005.06.484 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000641515
56 rdf:type schema:CreativeWork
57 https://doi.org/10.1016/j.ymthe.2005.11.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006270516
58 rdf:type schema:CreativeWork
59 https://doi.org/10.1016/s0168-9525(99)01777-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021937163
60 rdf:type schema:CreativeWork
61 https://doi.org/10.1128/mcb.24.20.9239-9247.2004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005783741
62 rdf:type schema:CreativeWork
63 https://www.grid.ac/institutes/grid.16416.34 schema:Organization
 




Preview window. Press ESC to close (or click here)


...